Education
About Us
Working with TipRanks
Follow Us
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -147.00K | $ -123.00K | $ -43.00K | $ -50.00K | $ -47.00K |
| Operating Income | $ -51.52M | $ -33.92M | $ -29.91M | $ -32.48M | $ -32.49M |
| EBITDA | $ -47.79M | $ -33.80M | $ -28.02M | $ -32.71M | $ -32.27M |
| Net Income | $ -47.91M | $ -29.07M | $ -29.15M | $ -33.94M | $ -32.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 107.62M | $ 82.97M | $ 120.51M | $ 36.83M | $ 45.00M |
| Total Assets | $ 110.90M | $ 89.40M | $ 123.02M | $ 38.48M | $ 47.13M |
| Total Debt | $ 1.03M | $ 1.34M | $ 9.18M | $ 14.63M | $ 14.21M |
| Net Debt | $ -33.06M | $ -31.06M | $ -3.41M | $ -22.20M | $ -30.79M |
| Total Liabilities | $ 11.26M | $ 6.86M | $ 15.56M | $ 21.40M | $ 19.85M |
| Stockholders' Equity | $ 99.64M | $ 82.55M | $ 107.46M | $ 17.07M | $ 27.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -38.29M | $ -31.85M | $ -28.33M | $ -28.95M | $ -29.03M |
| Operating Cash Flow | $ -38.26M | $ -31.71M | $ -28.18M | $ -28.95M | $ -29.00M |
| Investing Cash Flow | $ -21.53M | $ 59.43M | $ -107.37M | $ 0.00 | $ -32.00K |
| Financing Cash Flow | $ 61.48M | $ -7.91M | $ 111.31M | $ 20.77M | $ 16.72M |